ࡱ> ?A>Q "bjbj 8$ee6 6 {{{{{r ($"P%6 !{ {{, ```{{```A`))^ B 0r ,%z%A%{A` Fr %6 A: DPARTICIPANT INFORMATION SHEET (EXAMPLE) Research Title: Control of shivering during spinal anaesthesia : Prophylactic ketamine or tramadol in urological and lower limb orthopaedic surgery in ԭ Medical Centre Introduction: You are invited to participate in a research study. Before participating in this study, it is important that you take time to read and understand the information in this Information Sheet. Purpose of Study: Shivering that occurs associated with spinal anaesthesia is relatively common. It may lead to an unpleasant experience and may be stressful for the patient. Corrective measures can be taken to prevent shivering. These may include the use of blankets, warm air circulation to the patients and drugs. Several drugs are in use to prevent shivering. These include tramadol, ketamine and paracetamol among others. We are not sure which drug is the best prevention of shivering . The aim of this study is to compare the effectiveness of ketamine versus tramadol in the prevention of shivering during spinal anaesthesia. What will the study involve? You are about to undergo surgery with spinal anesthesia. This involves introduction of a needle into the spine and an anesthetic drug will be given through the needle. This will result in numbness of your abdomen for the surgery. After introduction of spinal anaesthesia, patients with be randomly chosen to be given one of the two drugs either ketamine or tramadol. The drug will be given as injection through the vein prior to surgery. The incidence and severity of shivering will be recorded during the operation. Benefits: There is unlikely to be a direct benefit for you in participating in this study. The drugs given may or may not help to reduce shivering during your surgery. However, your participation could help us improve on the prevention of shivering in future patients. Risks The risk of this study is mainly due to spinal anesthesia which include low blood pressure, headache, vomiting and back pain. The study drugs are given in low doses and are unlikely to cause side-effects such as increased in blood pressure, palpitations and nausea. Should you get any problems, we will give you medication to make you feel better. Do you have to take part? Participation in this study is voluntary. If you agree to take part, then you will be asked to sign the Informed Consent Form. You will be given a copy of the form and this Information Sheet. Your treatment is not affected if you decide not to participant in this study. You will undergo surgery under spinal anaesthesia as usual and you anaesthetist may or may not give you medication to prevent shivering. Should you decide to participate, you can still withdraw from the study without penalty. Your data will not be used and will be discarded. The researcher may also remove you from the study for a variety of reason. In this event, you will not be penalised or lose your rights as a patient. Data & Confidentiality: The data from this study will be made into a report which may be published. Access to the data is only by the research team and the REC ԭ. The data will be reported in a collective manner with no reference to an individual. Hence your identity will be kept confidential. Payment and compensation: You do not have to pay nor will you be paid to participate in this study. You do have to pay for the usual hospital charges. This study is being conducted with a ԭ Research Grant. You will be given a sum of RM xxx as travel reimbursement for this study. Should you develop complications related to the study, then treatment will be given at no cost to you. Who can I ask about the study? If you have any questions, you can direct them to the research team. You can also contact the REC ԭ for clarifications. Name: Principal Investigator Department of Anaesthesiology ԭMC Phone Number : 03-9145 XXXX Mobile : 012-XXX XXXX Name: Student Department of Anaesthesiology ԭMC Phone Number : 03-9145 XXXX Mobile : 012-XXX XXXX  &'()*89:;<r  < CDPSTͻͬ͝thttth[thH=5CJOJQJaJhCJOJQJaJhH=CJOJQJaJh5CJOJQJaJhH=hH=5CJOJQJaJhH=hH=CJOJQJaJhH=5>*䴳ϴ"=5>*䴳ϴ"5>*䴳ϴ";5>*䴳ϴ;5>*䴳ϴ#()*<   < # $ CDPTU[pdgdH= $da$gd[TUZEGfTUd"""ҵµµҩҝґҀuhH=hH=CJaJUhH=h<1CJOJQJaJhH=CJOJQJaJh<1CJOJQJaJh|NCJOJQJaJh5CJOJQJaJhH=hH=5CJOJQJaJhH=hH=CJOJQJaJhH=hR5CJOJQJaJhH=hRCJOJQJaJpq[\FGf#?UVddgd<1dgdH="dgdH= 6&P 1h:pH=. A!"#$% w666666666vvvvvvvvv666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@6666_HmH DnH DsH DtH DD`D  Normal$da$_HmH sH tH bb  Heading 1$<@&&5CJ KH OJQJ\aJ mHsHtHDD  Heading 2$@&CJmHsHtHPP  Heading 5$@&5CJOJQJmHsHtHDD  Heading 6$@&CJmHsHtHPP  Heading 8$@&5CJOJQJmHsHtHDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List R/R  Heading 1 Char5CJ KH OJQJ\^JaJ 8/8  Heading 2 CharCJD/D  Heading 5 Char5CJOJQJ8/!8  Heading 6 CharCJD/1D  Heading 8 Char5CJOJQJP%BP g0Envelope ReturndOJPJQJ^JDRD H= List Paragraph ^m$V^bV H= Normal (Web)$ddd[$\$a$CJaJ6U q6 H= Hyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVqu ѡ{5kP?O&Cנ Aw0kPo۵(h[5($=CVs]mY2zw`nKDC]j%KXK 'P@$I=Y%C%gx'$!V(ekڤք'Qt!x7xbJ7 o߼W_y|nʒ;Fido/_1z/L?>o_;9:33`=—S,FĔ觑@)R8elmEv|!ո/,Ә%qh|'1:`ij.̳u'k CZ^WcK0'E8S߱sˮdΙ`K}A"NșM1I/AeހQתGF@A~eh-QR9C 5 ~d"9 0exp<^!͸~J7䒜t L䈝c\)Ic8E&]Sf~@Aw?'r3Ȱ&2@7k}̬naWJ}N1XGVh`L%Z`=`VKb*X=z%"sI<&n| .qc:?7/N<Z*`]u-]e|aѸ¾|mH{m3CԚ .ÕnAr)[;-ݑ$$`:Ʊ>NVl%kv:Ns _OuCX=mO4m's߸d|0n;pt2e}:zOrgI( 'B='8\L`"Ǚ 4F+8JI$rՑVLvVxNN";fVYx-,JfV<+k>hP!aLfh:HHX WQXt,:JU{,Z BpB)sֻڙӇiE4(=U\.O. +x"aMB[F7x"ytѫиK-zz>F>75eo5C9Z%c7ܼ%6M2ˊ 9B" N "1(IzZ~>Yr]H+9pd\4n(Kg\V$=]B,lוDA=eX)Ly5ot e㈮bW3gp : j$/g*QjZTa!e9#i5*j5ö fE`514g{7vnO(^ ,j~V9;kvv"adV݊oTAn7jah+y^@ARhW.GMuO "/e5[s󿬅`Z'WfPt~f}kA'0z|>ܙ|Uw{@՘tAm'`4T֠2j ۣhvWwA9 ZNU+Awvhv36V`^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!g theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] $T" p" 8@0(  B S  ?_jAL  ) 5 g p r_l2B)1?G3333333&(CCDDSTUUZZ ETDDSTUUZZT L^`OJPJQJ^Jo(" ^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hHT C         3:l~$p-<1#(65v:DRW[`Nt;vGa|NgH=|}g m,+ olB7@@"Unknown G.[x Times New Roman5Symbol3. .[x Arial7..{$ Calibri7$BCambriaC.,.{$ Calibri Light?= .Cx Courier New;WingdingsA$BCambria Math"qhGjGGjG]!Yg Yg !d203QHP $PH=2!xx UKMUKM Oh+'0`    ( 4@HPXԭNormalԭ2Microsoft Office Word@@?Z@R(@R(Yg  ՜.+,0 hp|    Title  !"#$%&'()*+,-/012345789:;<=@Root Entry F`))BData 1Table%WordDocument8$SummaryInformation(.DocumentSummaryInformation86CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q